GlassScriptPhysician profile
Kenneth M Lemos
NPI 1750333209
$784.72
in general payments reported to CMS, 2019-2025
13 companies · $59.35 in 2025
The $59.35 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $237 · 2022: $183 · 2023: $268 · 2024: $37.97 · 2025: $59.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $409.61 | 2021-2024 | Xtampza |
| Protega Pharmaceutials INC | $117.41 | 2022-2023 | Roxybond |
| Otsuka America Pharmaceutical, INC. | $57.18 | 2021-2023 | Rexulti |
| Abbvie INC. | $52.65 | 2022-2023 | |
| Tactile Systems Technology INC | $24.36 | 2025 | Nimbl, Flexitouch Plus |
| Pacira Pharmaceuticals Incorporated | $23.31 | 2022 | |
| Verona Pharma, INC. | $17.80 | 2025 | Ohtuvayre |
| Exact Sciences Corporation | $17.19 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.93 | 2021 | |
| Pfizer INC. | $13.04 | 2023 | |
| Redhill Biopharma INC. | $12.72 | 2022 | |
| Eisai INC. | $12.03 | 2021 | |
| Avanir Pharmaceuticals, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Lemos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.